Labwire Stock Performance

LBWR Stock  USD 0.0003  0.00  0.00%   
Labwire holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.94, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Labwire are expected to decrease slowly. On the other hand, during market turmoil, Labwire is expected to outperform it slightly. Use Labwire market risk adjusted performance, jensen alpha, as well as the relationship between the Jensen Alpha and day typical price , to analyze future returns on Labwire.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Labwire are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Labwire reported solid returns over the last few months and may actually be approaching a breakup point. ...more
  

Labwire Relative Risk vs. Return Landscape

If you would invest  0.01  in Labwire on October 30, 2025 and sell it today you would earn a total of  0.02  from holding Labwire or generate 200.0% return on investment over 90 days. Labwire is currently generating 3.1746% in daily expected returns and assumes 25.1976% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Labwire, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Labwire is expected to generate 33.38 times more return on investment than the market. However, the company is 33.38 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Labwire Target Price Odds to finish over Current Price

The tendency of Labwire Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0003 90 days 0.0003 
about 13.14
Based on a normal probability distribution, the odds of Labwire to move above the current price in 90 days from now is about 13.14 (This Labwire probability density function shows the probability of Labwire Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Labwire has a beta of -0.94. This indicates In addition to that Labwire has an alpha of 3.0851, implying that it can generate a 3.09 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Labwire Price Density   
       Price  

Predictive Modules for Labwire

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Labwire. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Labwire's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000225.20
Details
Intrinsic
Valuation
LowRealHigh
0.000.000225.20
Details
Naive
Forecast
LowNextHigh
0.0000070.000325.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00030.00030.0003
Details

Labwire Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Labwire is not an exception. The market had few large corrections towards the Labwire's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Labwire, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Labwire within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
3.09
β
Beta against Dow Jones-0.94
σ
Overall volatility
0.0001
Ir
Information ratio 0.12

Labwire Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Labwire for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Labwire can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Labwire is way too risky over 90 days horizon
Labwire has some characteristics of a very speculative penny stock
Labwire appears to be risky and price may revert if volatility continues
The company has a current ratio of 0.49, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Labwire until it has trouble settling it off, either with new capital or with free cash flow. So, Labwire's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Labwire sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Labwire to invest in growth at high rates of return. When we think about Labwire's use of debt, we should always consider it together with cash and equity.
Labwire reported the previous year's revenue of 4.78 M. Net Loss for the year was (51.48 K) with profit before overhead, payroll, taxes, and interest of 1.79 M.

Labwire Fundamentals Growth

Labwire Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Labwire, and Labwire fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Labwire Pink Sheet performance.

About Labwire Performance

Assessing Labwire's fundamental ratios provides investors with valuable insights into Labwire's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Labwire is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Labwire, Inc., along with its subsidiary, Workplace Screening Services, provides employee screening services for Fortune 500 corporations in the United States. Labwire, Inc. was founded in 2004 and is headquartered in Brookshire, Texas. Labwire is traded on OTC Exchange in the United States.

Things to note about Labwire performance evaluation

Checking the ongoing alerts about Labwire for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Labwire help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Labwire is way too risky over 90 days horizon
Labwire has some characteristics of a very speculative penny stock
Labwire appears to be risky and price may revert if volatility continues
The company has a current ratio of 0.49, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Labwire until it has trouble settling it off, either with new capital or with free cash flow. So, Labwire's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Labwire sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Labwire to invest in growth at high rates of return. When we think about Labwire's use of debt, we should always consider it together with cash and equity.
Labwire reported the previous year's revenue of 4.78 M. Net Loss for the year was (51.48 K) with profit before overhead, payroll, taxes, and interest of 1.79 M.
Evaluating Labwire's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Labwire's pink sheet performance include:
  • Analyzing Labwire's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Labwire's stock is overvalued or undervalued compared to its peers.
  • Examining Labwire's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Labwire's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Labwire's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Labwire's pink sheet. These opinions can provide insight into Labwire's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Labwire's pink sheet performance is not an exact science, and many factors can impact Labwire's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Labwire Pink Sheet Analysis

When running Labwire's price analysis, check to measure Labwire's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Labwire is operating at the current time. Most of Labwire's value examination focuses on studying past and present price action to predict the probability of Labwire's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Labwire's price. Additionally, you may evaluate how the addition of Labwire to your portfolios can decrease your overall portfolio volatility.